Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amrep (AXR) Gains from Sales and Divestitures (2017 - 2025)

Historic Gains from Sales and Divestitures for Amrep (AXR) over the last 12 years, with Q4 2025 value amounting to $15715.0.

  • Amrep's Gains from Sales and Divestitures rose 715.26% to $15715.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $15715.0, marking a year-over-year increase of 715.26%. This contributed to the annual value of $500000.0 for FY2025, which is 0.0% changed from last year.
  • Per Amrep's latest filing, its Gains from Sales and Divestitures stood at $15715.0 for Q4 2025, which was up 715.26% from $15715.0 recorded in Q3 2025.
  • In the past 5 years, Amrep's Gains from Sales and Divestitures registered a high of $500000.0 during Q2 2021, and its lowest value of $9833.0 during Q3 2022.
  • For the 5-year period, Amrep's Gains from Sales and Divestitures averaged around $135792.9, with its median value being $15190.5 (2024).
  • Per our database at Business Quant, Amrep's Gains from Sales and Divestitures surged by 11578.95% in 2021 and then tumbled by 5203.41% in 2022.
  • Amrep's Gains from Sales and Divestitures (Quarter) stood at $20500.0 in 2021, then plummeted by 52.03% to $9833.0 in 2022, then grew by 24.06% to $12199.0 in 2023, then rose by 20.22% to $14666.0 in 2024, then increased by 7.15% to $15715.0 in 2025.
  • Its Gains from Sales and Divestitures was $15715.0 in Q4 2025, compared to $15715.0 in Q3 2025 and $500000.0 in Q2 2025.